Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29 900 patients
RW Thomsen, A Riis, JB Kornum… - Archives of internal …, 2008 - jamanetwork.com
Background While some experimental and clinical research suggests that statins improve
outcomes after severe infections, the evidence for pneumonia is conflicting. We examined
whether preadmission statin use decreased risk of death, bacteremia, and pulmonary
complications after pneumonia. Methods We conducted a population-based cohort study of
29 900 adults hospitalized with pneumonia for the first time between January 1, 1997, and
December 31, 2004 in northern Denmark. Data on statin and other medication use …
outcomes after severe infections, the evidence for pneumonia is conflicting. We examined
whether preadmission statin use decreased risk of death, bacteremia, and pulmonary
complications after pneumonia. Methods We conducted a population-based cohort study of
29 900 adults hospitalized with pneumonia for the first time between January 1, 1997, and
December 31, 2004 in northern Denmark. Data on statin and other medication use …